VWF and COVID-19: Different mechanisms have been implicated in the pathogenesis of SVT thrombosis in COVID-19 patients [58], including: high release of proinflammatory cytokines, endothelial direct damage by the virus, increased procoagulant factors (notably VIII-F, vWF and V-F) and NETs [54,59,60].